“…Because of its non-invasive nature, highly controlled sham condition, and relatively low cost compared to other neuromodulation techniques, tDCS quickly arises as a promising therapeutic tool. Indeed, many several systematic reviews and meta-analyses of randomized controlled trials indicated the safety and therapeutic efficacy of tDCS for a wide range of mental disorders (for a review, see Tortella et al, 2015), including, among others, depression and mood disorders (Borrione et al, 2018;Dondé et al, 2018;Razza et al, 2020), anxiety disorders (e.g., Stein et al, 2020;Yosephi et al, 2019), psychotic disorders (e.g., Lee et al, 2018), pain-related disorders (e.g., Zortea et al, 2019), and eating disorders (e.g., Dalton et al, 2018). Hence, this literature has prompted an exceptionally positive prospect vis-à-vis tDCS as a therapeutic tool.…”